Literature DB >> 3179685

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome.

M D Kopelman1, T H Corn.   

Abstract

The effect of cholinergic 'blockade' on human memory performance as a model for the effect of cholinergic depletion in clinical disorders was investigated. A wide range of memory functions was assessed in 70 subjects, using tests which were identical or closely similar to those which have previously been employed in clinical studies of Alzheimer and Korsakoff patients. In addition, a physiological measure of the degree of central cholinergic blockade was included, as well as measures of subjective arousal and objective attention. It was found that cholinergic blockade had no significant effect on the more passive aspects of primary (or 'working') memory, namely span tests and a measure of verbal short-term forgetting; in this, it contrasts with the marked deficits seen in Alzheimer-type dementia. On the other hand, cholinergic blockade produced impairment at a visuospatial short-term forgetting test, and at a verbal test in which the distractor task was made more difficult. On tests of secondary memory, cholinergic blockade produced a pattern similar to that seen in the anterograde amnesia of Alzheimer and Korsakoff patients, namely a pronounced impairment in learning verbal and visuospatial material, a 'normal' forgetting rate once learning had been accomplished, and relative preservation of the response to priming and of skill learning (procedural memory). Cholinergic blockade, however, did not produce a retrograde amnesia, nor did it affect the recall of temporal context or of long-established semantic knowledge. This pattern of results is compared with that obtained in previous studies of Alzheimer and Korsakoff patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179685     DOI: 10.1093/brain/111.5.1079

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  50 in total

1.  Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory.

Authors:  M Alreja; M Wu; W Liu; J B Atkins; C Leranth; M Shanabrough
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Probing peripheral and central cholinergic system responses.

Authors:  C A Naranjo; J Fourie; N Herrmann; K L Lanctôt; C Birt; K K Yau
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

3.  Beneficial effects of electrostimulation contingencies on sustained attention and electrocortical activity.

Authors:  Max Jean-Lon Chen; Trevor Thompson; Juri Kropotov; John H Gruzelier
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

4.  Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study.

Authors:  Julie A Dumas; Brenna C McDonald; Andrew J Saykin; Thomas W McAllister; Mary L Hynes; John D West; Paul A Newhouse
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

5.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

Review 6.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.

Authors:  L Preda; M Alberoni; S Bressi; C Cattaneo; J Parini; N Canal; M Franceschi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  A comparison of the amnesic effects of lorazepam in alcoholics and non-alcoholics.

Authors:  J L Mallick; K C Kirkby; F Martin; M Philp; M J Hennessy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall.

Authors:  F Schifano; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.